ArticleThe Journal of clinical investigation2023

Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.